Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111616 · ClinicalTrials.gov registry record · NA
Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT02111616 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 37 participants.
The verdict
NCT02111616, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Purpose: Cancer survivorship is a high clinical and research priority both nationally and at the University of North Carolina. The investigators propose a randomized pilot study testing the development, implementation and evaluation of a parallel patient and streamlined provider version of a personalized Survivorship Care Plan (SCP) with lung cancer patients. Participants: 60 lung cancer patients at Rex Cancer Center. Procedures (methods): Participants will be recruited and randomized to the standard of care (30 patients) or intervention (30 patients) arm. Patients randomized to standard of care will receive a tailored survivorship care plan at the end of cancer treatment. Patients randomized to the intervention will receive a care plan and coordinating visit with their primary care provider. Patients will be invited to complete baseline and follow-up assessments regarding care needs and confidence in post cancer care. All patient primary care providers will receive condensed provider versions of the care plan. Providers will be asked to evaluate how the SCP and coordinated care visit (intervention only) facilitated communication and coordination of care.
Interventions
- BEHAVIORAL Survivorship Care Plan (SCP)
- BEHAVIORAL Coordinated PCP visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111616
The ClinicalTrials.gov registry entry for NCT02111616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survivorship Care Plan (SCP) is the first listed.
NCT02111616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111616 about?
NCT02111616 is a clinical study titled "Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study". Purpose: Cancer survivorship is a high clinical and research priority both nationally and at the University of North Carolina. The investigators propose a randomized pilot study testing the development, implementation and evaluation of a parallel patient and streamlined provider version of a persona...
What is the current status of trial NCT02111616?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2013-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02111616?
The interventions under investigation include: Survivorship Care Plan (SCP) (BEHAVIORAL), Coordinated PCP visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT02111616?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.